Close

Jefferies Cuts Price Target on OneMain Holdings (OMF) to $30; Reiterates Buy

Go back to Jefferies Cuts Price Target on OneMain Holdings (OMF) to $30; Reiterates Buy

Keefe, Bruyette & Woods Downgrades OneMain (OMF) to Market Perform

November 8, 2016 7:17 AM EST

Keefe, Bruyette & Woods downgraded OneMain (NYSE: OMF) from Outperform to Market Perform with a price target of $24.00 (from $41.00).

For an analyst ratings summary and ratings history on OneMain click here. For more ratings news on OneMain click here.

Shares of OneMain closed at $27.57 yesterday.

... More

BofA/Merrill Lynch Downgrades OneMain (OMF) to Underperform

November 8, 2016 7:11 AM EST

BofA/Merrill Lynch downgraded OneMain (NYSE: OMF) from Buy to Underperform with a price target of $21.

For an analyst ratings summary and ratings history on OneMain click here. For more ratings news on OneMain click here.

Shares of OneMain closed at $27.57 yesterday.

... More

FBR Capital Downgrades OneMain (OMF) to Market Perform; Credit Deteriorates and Growth Slows

November 8, 2016 6:53 AM EST

FBR Capital downgraded OneMain (NYSE: OMF) from Outperform to Market Perform with a price target of $26.00 (from $40.00) as credit deteriorates and growth slows.

Analyst Bob Ramsey commented, "We downgrade shares of OneMain Holdings to Market Perform from Outperform following 3Q16 results. Our prior... More

OneMain Holdings (OMF) Reports Q3 EPS of 90c

November 7, 2016 4:44 PM EST

OneMain Holdings (NYSE: OMF) reported Q3 EPS of $0.90, may not compare to the analyst estimate of $1.07.

For earnings history and earnings-related data on OneMain Holdings (OMF) click here.

... More

Trading Radar for 11/7: MGM Resorts (MGM), LendingClub (LC), Dean Foods (DF), Ferrari (RACE), Sysco (SYY) Report

November 4, 2016 3:49 PM EDT

The Trading Radar highlights key earnings and economic announcements for the next trading session:

Before Markets Open:
Earnings:

ARIAD Pharma (Nasdaq: ARIA) - consensus loss $0.19
Altisource Residential (Nasdaq: RESI) - consensus loss $0.48
Amicus Therapeutics (Nasdaq: FOLD) - consensus loss $0.34
ArQule (Nasdaq: ARQL) - consensus loss $0.09
Aralez Pharma (Nasdaq: ARLZ) - consensus loss $0.37
Ardelyx (Nasdaq: ARDX) -... More